Literature DB >> 24938234

[The morbidity diagnosed among the elderly in primary care at the sanitary region of Sousse].

Chekib Zedini, Thouraya Ajmi Nabli, Iheb Bougmiza, Mariem El Ghardallou, Manal Mallouli, Manal Limam, Ali Mtiraoui.   

Abstract

BACKGROUND: Nowadays, the ageing of the population became a societal frequent problem throughout the world. In Tunisia, the part of the elderly of 60 years old and over is estimated at 17,7 % in 2029. This ageing is at the origin of important health problems, in particular the increase of the frequency of the chronic diseases. AIM: To identify the Sociodemographic characteristics of the consultants of 65 years old and over, and to describe the morbidity diagnosed in this age group in the primary health care centers of the sanitary region of Sousse.
METHODS: We conducted a cross-sectional descriptive study in 86 primary health care centers in Sousse over 1 year (2002-2003). Medical records for 3 weeks per season were randomly selected. The International Classification of Primary Care (ICPC) was used to code recorded data.
RESULTS: 2198 consultations were collected, elderly person presents on average 1,22 (± 0,55) morbid states by consultation. The main diseases identified in order were cardiovascular (26,2%), breathing (20,8%), osteo-articular (14,8%). Psychological and social disorders accounted for only 0,4% of cases. The major health problems were uncomplicated hypertension (22,4%), acute bronchitis / bronchiolitis (9,2%), diabetes mellitus type 2 (7,9%) and osteoarthritis of knee (4,7%).
CONCLUSION: These results are important both to meet the needs of consultants and especially to better adapt the training to practice field.

Entities:  

Mesh:

Year:  2014        PMID: 24938234

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  1 in total

Review 1.  Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis.

Authors:  Anthony Usenbo; Veronika Kramer; Taryn Young; Alfred Musekiwa
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.